Point Of Care Glucose Testing Market Research Report Information By Product Type (Lancing Devices and Strips and Blood-Glucose Meter), By Application (Type-1 Diabetes and Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Lancing Devices and Strips

6.3. Blood-Glucose Meter

7. GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION

7.1. Overview

7.2. Product Type-1 Diabetes

7.3. Product Type-2 Diabetes

8. GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY END USER

8.1. Overview

8.2. Hospitals and Clinics

8.3. Home Care Settings

8.4. Others

9. GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Point of care glucose testing Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Point of care glucose testing Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Nova Biomedical Corporation

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Nipro

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. ACON Laboratories, Inc.

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Trividia Health, Inc.

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Platinum Equity Advisors LLC

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Ascensia Diabetes Care Holdings AGG

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. PRODIGY DIABETES CARE LLC

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. F. Hoffmann-La Roche Ltd

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. EKF Diagnostics Holdings plc

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 9 US: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 10 US: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 11 US: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 12 CANADA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 13 CANADA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 14 CANADA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 15 EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 16 EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 18 GERMANY: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 19 GERMANY: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 20 GERMANY: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 21 FRANCE: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 22 FRANCE: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 FRANCE: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 24 ITALY: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 25 ITALY: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 26 ITALY: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 27 SPAIN: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 28 SPAIN: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 SPAIN: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 30 UK: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 31 UK: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 32 UK: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 33 REST OF EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 34 REST OF EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 35 REST OF EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 36 ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 37 ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 38 ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 39 JAPAN: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 40 JAPAN: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 41 JAPAN: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 42 CHINA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 43 CHINA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 CHINA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 45 INDIA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 46 INDIA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 INDIA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 48 AUSTRALIA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 49 AUSTRALIA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 AUSTRALIA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 51 SOUTH KOREA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 52 SOUTH KOREA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53 SOUTH KOREA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 54 REST OF ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 55 REST OF ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56 REST OF ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 57 REST OF THE WORLD: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 58 REST OF THE WORLD: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59 REST OF THE WORLD: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 60 MIDDLE EAST: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 61 MIDDLE EAST: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62 MIDDLE EAST: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 63 AFRICA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 64 AFRICA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 65 AFRICA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 66 LATIN AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)

TABLE 67 LATIN AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 68 LATIN AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, BY END USER, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL POINT OF CARE GLUCOSE TESTING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL POINT OF CARE GLUCOSE TESTING MARKET

FIGURE 4 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY PRODUCT TYPE, 2022

FIGURE 5 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY END USER, 2022

FIGURE 7 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: POINT OF CARE GLUCOSE TESTING MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL POINT OF CARE GLUCOSE TESTING MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 ABBOTT LABORATORIES: SWOT ANALYSIS

FIGURE 15 NOVA BIOMEDICAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 NOVA BIOMEDICAL CORPORATION: SWOT ANALYSIS

FIGURE 17 NIPRO: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 NIPRO: SWOT ANALYSIS

FIGURE 19 ACON LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 ACON LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 21 TRIVIDIA HEALTH, INC..: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 TRIVIDIA HEALTH, INC..: SWOT ANALYSIS

FIGURE 23 PLATINUM EQUITY ADVISORS LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 PLATINUM EQUITY ADVISORS LLC: SWOT ANALYSIS

FIGURE 25 ASCENSIA DIABETES CARE HOLDINGS AGG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 ASCENSIA DIABETES CARE HOLDINGS AGG: SWOT ANALYSIS

FIGURE 27 PRODIGY DIABETES CARE LLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 PRODIGY DIABETES CARE LLC: SWOT ANALYSIS

FIGURE 29 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS

FIGURE 31 EKF DIAGNOSTICS HOLDINGS PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 EKF DIAGNOSTICS HOLDINGS PLC: SWOT ANALYSIS